Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Dana Chase

Gyn Onc · UCLA

View

Dr. Ashley Stuckey

Gyn Onc · Women & Infants Hospital

View

Dr. Susan Khalil

MIGS · ISMMS

View

Dr. Tori O’Daniel

OB Hospitalist · Laborie-MCH division, Senior Medical Director

View

Dr. Alissa Erogbogbo

OB Hospitalist · Washington Health System

View

Dr. Christina Adams

OB Hospitalist · Flagler Hospital

View

Dr. Brigid McCue

OB Hospitalist · Northwell Health

View

Dr. Bruce Bekkar

General OBGYN · ecoAmerica

View

Dr. Jennifer Lincoln

OB Hospitalist · Providence

View

Dr. Stephanie McNally

Menopause · Northwell Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    KRDr. Kimberly Resnick
    Leading Voice

    Dr. Kimberly Resnick

    Obstetrics & Gynecology (OBGYN) · Gynecologic Oncology
    The Metrohealth System
    drkimberlyresnick
    Cleveland, OH

    Research

    Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

    2023

    Via Journal of Clinical Oncology

    Research

    Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.

    2021

    Via JCO Precision Oncology

    Research

    The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis.

    2019

    Via Cancer Research

    Research

    Preoperative frailty is a risk factor for non-home discharge in patients undergoing surgery for endometrial cancer.

    2018

    Via Journal of Geriatric Oncology

    Research

    The Prognostic Value of Baseline Lymphocyte, Neutrophil, and Monocyte Counts in Locally Advanced Cervical Carcinoma Treated with Radiation.

    2017

    Via Obstetrics and Gynecology International

    Research

    Lynch Syndrome and Endometrial Cancer.

    2017

    Via Southern Medical Journal

    Research

    High-dose chemotherapy and stem-cell rescue for salvage therapy for relapsed malignant mixed ovarian germ cell tumor: A case report.

    2017

    Via Gynecologic Oncology Reports

    Research

    Longer operative time is associated with increased post-operative complications in patients undergoing minimally-invasive surgery for endometrial cancer.

    2017

    Via Gynecologic Oncology

    Research

    Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.

    2017

    Via Oncogene

    Research

    Preoperative predictors of delay in initiation of adjuvant chemotherapy in patients undergoing primary debulking surgery for ovarian cancer.

    2016

    Via Gynecologic Oncology

    Research

    Fertility-sparing management of a stage IB1 small cell neuroendocrine cervical carcinoma with radical abdominal trachelectomy and adjuvant chemotherapy.

    2015

    Via Gynecologic Oncology Reports

    Research

    Patterns of First Recurrence in African American Patients with High Grade Epithelial Ovarian Carcinoma.

    2015

    Via Gynecologic and Obstetric Investigation

    Research

    Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.

    2013

    Via Gynecologic Oncology

    Research

    A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

    2012

    Via Gynecologic Oncology

    Research

    Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies.

    2012

    Via Frontiers in Oncology